Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age
Pediatric Allergy and Immunology · 2024-07 · 35 (7)
DOI: 10.1111/pai.14192 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 15.07.2024. Verfasst von Hajime Yoshisue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Pharma K.K., Tokyo, Japan. Hauptthemen laut MEDLINE: Food Hypersensitivity, Anaphylaxis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
While food allergy (FA) has been increasingly recognized as a growing public health burden worldwide, epidemiological studies on FA in Japan are limited.
Methods
This was a noninterventional, observational study using the administrative claims data from 2010 to 2019 (10 years). Patients with physician‐diagnosed FA in Japan (prevalent cohort) were divided into high‐risk or low‐risk cohorts using adrenaline prescription. The high‐risk cohort was further divided into anaphylaxis or nonanaphylaxis cohort based on the occurrence of anaphylaxis or a serious allergic reaction (SAR) during 1 year after adrenaline prescription. The primary objective was to examine yearly prevalence of FA. The secondary objectives were to describe demographics/clinical characteristics and healthcare resource utilization (HCRU), to evaluate the number of occurrences of anaphylaxis/SAR in the high‐risk cohort, and the impact of anaphylaxis/SAR on HCRU.
Results
The overall standardized prevalence rate was 0.325% (95% confidence interval [CI], 0.311–0.339) in 2010 and 0.797% (95% CI, 0.790–0.804) in 2019 and predominant in patients age 80%) were children/adolescent throughout the 10 years. While high‐risk cohort was a relatively minor population (8.5% in the prevalent cohort in 2019), the occurrence of anaphylaxis/SAR in the high‐risk cohort was 227,690/100,000 patient‐years. Multivariate analysis showed a significant increase in HCRU variables in the anaphylaxis versus nonanaphylaxis cohort (e.g., 2.08 [95% CI, 2.05–2.11] times more FA‐related outpatient visits).
Conclusions
Prevalence of FA increased in a statistically significant way from 2010 to 2019; 1.7‐fold increase was observed in patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Novartis Pharma K.K., Tokyo, Japan.
- JMDC Co. Ltd, Tokyo, Japan.
- Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
ORCID-Profile: Hajime Yoshisue, Motohiro Ebisawa
Zitieren
APA
Yoshisue, H., Homma, Y., Ito, C., & Ebisawa, M. (2024). Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age. Pediatric Allergy and Immunology, 35(7). https://doi.org/10.1111/pai.14192
Vancouver
Yoshisue H, Homma Y, Ito C, Ebisawa M. Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age. Pediatric Allergy and Immunology. 2024;35(7). doi:10.1111/pai.14192
BibTeX
@article{Yoshisue2024,
author = {Yoshisue, Hajime and Homma, Yuji and Ito, Chie and Ebisawa, Motohiro},
title = {Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age},
journal = {Pediatric Allergy and Immunology},
year = {2024},
volume = {35},
number = {7},
doi = {10.1111/pai.14192}
}
EUVIMED